US Patent Issued to Sitryx Therapeutics on July 14 for "Compounds" (British Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,419, issued on July 14, was assigned to Sitryx Therapeutics Ltd. (Oxford, Great Britain).

"Compounds" was invented by Matthew Colin Thor Fyfe (Oxford, Great Britain) and Barry John Teobald (Oxford, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to compounds of formula (I) and to their use in treating or preventing an inflammatory disease or a disease associated with an undesirable immune response: wherein RA1, RA2, RA3, RB, RC, RD, m, n and p are as defined herein."

The patent was filed on Oct. 27, 2021, under Application No. 18/034,122.

*For further information, including images, charts and tables, please visit...